TY  - JOUR

T1  - A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

JO  - Cancer Chemotherapy and Pharmacology

PY  - 2004/04/01

AU  - Gumbrell LA

AU  - Evans TRJ

AU  - Coleman RE

AU  - Smith IE

AU  - Twelves CJ

AU  - Soukop M

AU  - Rea DW

AU  - Earl HM

AU  - Howell A

AU  - Jones A

AU  - Canney P et al

ED  - 

DO  - DOI: 10.1007/s00280-003-0733-6

PB  - Springer Science and Business Media LLC

VL  - 53

IS  - 4

SP  - 341

EP  - 348

Y2  - 2025/10/10

ER  -